Clinical Trials Logo

Heart Failure NYHA Class II clinical trials

View clinical trials related to Heart Failure NYHA Class II.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03947853 Withdrawn - Heart Failure Clinical Trials

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

THETIS
Start date: October 1, 2019
Phase:
Study type: Observational

Cardiac Heart Failure Questionnaire HF-Q) to assess the severity of the symptoms of Heart Failure. In this study, modified and translated, the "four-point" questionnaire by Severo and his associates - Heart Failure Questionnaire HF-Q, is used. The HF-Q Heart Failure Questionnaire consists of four closed questions: the first with four possible answers and the other three questions with the possibility of three simple-choice answers.

NCT ID: NCT03005184 Withdrawn - Clinical trials for Heart Failure NYHA Class III

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Start date: September 2017
Phase: Phase 2
Study type: Interventional

This study tests the hypothesis that endogenous bradykinin contributes to effects of a combined angiotensin receptor blocker/neprilysin inhibitor (LCZ696 or Entresto)